Welcome to KAHR Medical
The mission at KAHR Medical is to develop novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases.
The company's drug development pipeline is built around 'trans signal converter proteins (TSCP)' - a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another.  Read More...
Quicktime for Mac   Windows Media Player Animated clip: TSCP technology in autoimmune

 

News & Events
 Globes, Israel's premier business newspaper, presents a video web report on KAHR Medical. (View the report's English version on Utube) 
 

 
  Copyrights, 2008 KAHR medical Ltd. All rights reserved
  Terms of Use | Privacy Policy | Contact Us